CN
Carmine N. Stengone sold $40K of CTNM stock
Carmine N. Stengone, CEO and President of Contineum Therapeutics, Inc. (CTNM), sold 2,500 shares of CTNM stock worth $40K, per an SEC Form 4 filed Aug 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Aug 3, 2026.
CTNM has moved -43.3% since the trade date, from $15.93 to $9.04 (Nov 19, 2026 close).
- Traded
- Aug 3, 2026
- Disclosed
- Aug 3, 2026
- Filing delay
- 0 days
- Price since
- -43.3%
- Role
- CEO and President
- Source
- SEC Form 4